{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Otto AK"],"funding":["Duncan Family Institute for Cancer Prevention and Risk Assessment","MD Anderson&apos;s Cancer Center Support Grant","American Cancer Society","Rising Tide Foundation","Richard E. Haynes Distinguished Professorship for Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center","NCI NIH HHS","National Institutes of Health"],"pagination":["e0297077"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10939216"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["19(3)"],"pubmed_abstract":["<h4>Objective</h4>Little evidence exists on the impact of the COVID-19 pandemic on cancer survivors, limiting recommendations to improve health-related quality of life (HRQoL) in this population. We describe survivors' pandemic experiences and examine associations between COVID-19-related exposures, psychosocial experiences, and HRQoL.<h4>Methods</h4>Between May 2020-April 2021, survivors completed cross-sectional questionnaires capturing COVID-19-related exposures (e.g., exposure to virus, job loss); psychosocial experiences (i.e., COVID-19-related anxiety/depression, disruptions to health care and daily activities/social interactions, satisfaction with providers' response to COVID, financial hardship, perceived benefits of the pandemic, social support, and perceived stress management ability); and HRQoL.<h4>Results</h4>Data were collected from N = 11,325 survivors in the United States. Participants were mostly female (58%), White (89%) and non-Hispanic (88%), and age 63 on average. Breast cancer was the most common diagnosis (23%). Eight percent of participants reported being exposed to COVID-19; 1% tested positive. About 6% of participants lost their jobs, while 24% lost household income. Nearly 30% avoided attending in-person oncology appointments because of the pandemic. Poorer HRQoL was associated with demographic (younger age; female; non-Hispanic White), clinical (Medicare; stage IV disease; hematologic/digestive/respiratory system cancer), and psychosocial factors (low perceived benefits and stress management ability; more disruption to health care and daily activities/social interactions; financial hardship).<h4>Conclusions</h4>COVID-19-related stressors were associated with various psychosocial experiences in cancer survivors, and these psychosocial experiences were associated with HRQoL above and beyond demographic and clinical factors."],"journal":["PloS one"],"pubmed_title":["Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States."],"pmcid":["PMC10939216"],"funding_grant_id":["CA016672","P30 CA016672","P30 CA240139","U01 CA206110","CA240139"],"pubmed_authors":["McQuade JL","Ahmed S","Antoni MH","Cohen L","Wagner RW","Prinsloo S","Tworoger SS","Bower JE","Peoples AR","Gomez TI","Penedo FJ","Ulrich CM","Ochoa JM","Natori A","Otto AK"],"additional_accession":[]},"is_claimable":false,"name":"Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States.","description":"<h4>Objective</h4>Little evidence exists on the impact of the COVID-19 pandemic on cancer survivors, limiting recommendations to improve health-related quality of life (HRQoL) in this population. We describe survivors' pandemic experiences and examine associations between COVID-19-related exposures, psychosocial experiences, and HRQoL.<h4>Methods</h4>Between May 2020-April 2021, survivors completed cross-sectional questionnaires capturing COVID-19-related exposures (e.g., exposure to virus, job loss); psychosocial experiences (i.e., COVID-19-related anxiety/depression, disruptions to health care and daily activities/social interactions, satisfaction with providers' response to COVID, financial hardship, perceived benefits of the pandemic, social support, and perceived stress management ability); and HRQoL.<h4>Results</h4>Data were collected from N = 11,325 survivors in the United States. Participants were mostly female (58%), White (89%) and non-Hispanic (88%), and age 63 on average. Breast cancer was the most common diagnosis (23%). Eight percent of participants reported being exposed to COVID-19; 1% tested positive. About 6% of participants lost their jobs, while 24% lost household income. Nearly 30% avoided attending in-person oncology appointments because of the pandemic. Poorer HRQoL was associated with demographic (younger age; female; non-Hispanic White), clinical (Medicare; stage IV disease; hematologic/digestive/respiratory system cancer), and psychosocial factors (low perceived benefits and stress management ability; more disruption to health care and daily activities/social interactions; financial hardship).<h4>Conclusions</h4>COVID-19-related stressors were associated with various psychosocial experiences in cancer survivors, and these psychosocial experiences were associated with HRQoL above and beyond demographic and clinical factors.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2026-06-27T03:23:00.197Z","creation":"2026-06-27T03:18:10.296Z"},"accession":"S-EPMC10939216","cross_references":{"pubmed":["38484002"],"doi":["10.1371/journal.pone.0297077"]}}